The abbreviated impactor measurement (AIM) concept: Part 1 - Influence of particle bounce and re-entrainment - Evaluation with a "dry" pressurized metered dose inhaler (pMDI)-Based formulation

AAPS PharmSciTech

Volumn 10, Issue 1, 2009, Pages 243-251

  Mitchell, J P ^a   Nagel, M W ^a   Avvakoumova, V ^a   MacKay, H ^a   Ali, R ^a  

^a TRUDELL MEDICAL INTERNATIONAL   (Canada)

Author keywords

Cascade impactor; Inhaler testing; Particle bounce; Particle re entrainment; Particle size distribution

Indexed keywords

FLUTICASONE PROPIONATE; HFA FLOVENT; UNCLASSIFIED DRUG; RESPIRATORY TRACT AGENT;

ABBREVIATED IMPACTOR MEASUREMENT; AEROSOL; ARTICLE; BIOTECHNOLOGICAL PROCEDURES; DRUG FORMULATION; DRUG MANUFACTURE; EQUIPMENT DESIGN; METERED DOSE INHALER; PARTICLE SIZE; PROCESS DEVELOPMENT; CHEMISTRY; COMPARATIVE STUDY; INHALATIONAL DRUG ADMINISTRATION; INSTRUMENTATION; MATERIALS TESTING; PHARMACEUTICS; PRESSURE; REPRODUCIBILITY; VALIDATION STUDY;

ADMINISTRATION, INHALATION; AEROSOLS; EQUIPMENT DESIGN; MATERIALS TESTING; METERED DOSE INHALERS; PARTICLE SIZE; PRESSURE; REPRODUCIBILITY OF RESULTS; RESPIRATORY SYSTEM AGENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 67549136514     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9202-9     Document Type: Article

References (32)

1. European Pharmacopeia. Section 2.9.18 - Preparations for Inhalation: Aerodynamic Assessment of Fine Particles, 5th ed., Council of Europe, Strasbourg, 2005, pp. 2799-2811.
2. United States Pharmacopeia. USP 30-NF 25. Chapter 601 - Physical Tests and Determinations: Aerosols, United States Pharmacopeia, Rockville, 2007, pp. 220-240.
3. V. A. Marple, D. L. Roberts, F. J. Romay, N. C. Miller, K. G. Truman, M. Van Oort, B. Olsson, M. J. Holroyd, J. P. Mitchell, and D. Hochrainer. Next generation pharmaceutical impactor. Part 1: Design. J. Aerosol Med. 16: 283-299 (2003).
4. J. Heyder, and M. U. Svartengren. Basic principles of particle behavior in the human respiratory tract. In H. Bisgaard, C. O'Callaghan, and G.C. Smaldone (eds.), Drug delivery to the lung, Marcel Dekker, New York, 2002, pp. 21-45.
5. G. Rudolph, R. Kobrich, and W. Stahlhofen. Modeling and algebraic formulation of regional aerosol deposition in man. J. Aerosol Sci. 21(S1):S403-S406 (1990).
6. J. P. Mitchell, and M. W. Nagel. Cascade impactors for the size characterization of aerosols from medical inhalers: Their uses and limitations. J. Aerosol Med. 16:341-377 (2003).
7. D. Christopher, P. Curry, B. Doub, K. Furnkranz, M. Lavery, K. Lin, S. Lyapustina, J. Mitchell, B. Rogers, H. Strickland, T. Tougas, Y. Tsong, and B. Wyka. Considerations for the development and practice of cascade impaction testing including a mass balance failure investigation tree. J. Aerosol Med. 16: 235-247 (2003).
8. S. Nichols, and D. Russell-Graham. Comparative Efficiency of the Use of the Next Generation Impactor Compared to the Andersen Cascade Impactor when Used with Dry Powder Inhalers. Drug Delivery to the Lungs-18, The Aerosol Society, London, 2007, pp. 120-123.
9. M. Van Oort, and W. Roberts. Variable flow-variable stage-variable volume strategy for cascade impaction testing of inhalation aerosols. In R. N. Dalby, P. R. Byron, and S. J. Farr (eds.), Respiratory Drug Delivery-V, Interpharm, Buffalo Grove, 1996, pp. 418-420.
10. H. Lundbäck, and B. Wiktorsson. High throughput inhaler testing I: Fine particle dose. In R. N. Dalby, P. R. Byron, J. Peart, J. D. Suman, and S. J. Farr (eds.), Respiratory Drug Delivery 2006, Davis Healthcare, River Grove, 2006, pp. 467-469.
11. M. Bonam, D. Christopher, D. Cipolla, B. Donovan, D. Goodwin, S. Holmes, S. Lyapustina, J. Mitchell, S. Nichols, G. Pettersson, C. Quale, N. Rao, D. Singh, T. Tougas, M. Van Oort, B. Walther, and B. Wyka. Minimizing variability of cascade impaction measurements in inhalers and nebulizers. AAPS PharmSciTech. 9 (2):404-413 (2008) http://www.springerlink.com/content/t22701k84w1665q4/ doi: 10.1208/ s12249-008-9045-9. Accessed 5/10/2008.
12. J. P. Mitchell, and C. Dunbar. Analysis of cascade impactor mass distributions. J. Aerosol Med. 18(4):439-451 (2005).
13. J. P. Mitchell. The role of aerosol measurement for aerodynamic particle size distribution (APSD) in a quality-by-design (QbD) environment. In R. N. Dalby, P. R. Byron, J. Peart, J. D. Suman, S. J. Farr, and P. M. Young (eds.), Respiratory Drug Delivery 2008, Davis Healthcare, River Grove, 2008, pp. 779-783.
14. J. P. Mitchell. The Abbreviated Impactor Measurement (AIM) concept for aerodynamic particle size distribution (APSD) in a quality-by-design (QbD) environment. In: Proc. Biennial IPAC-RS Conference, Bethesda, MD, USA. 2008. http://www.ipacrs.com/ipac2008.html. Accessed 5/10/2008.
15. V. A. Marple, B. A. Olson, and N. C. Miller. The role of inertial particle collectors in evaluating pharmaceutical aerosol delivery systems. J. Aerosol Med. 11(S1):S-139-S-153 (1998).
16. D. L. Roberts, and F. J. Romay. Relation of stage mensuration data to the performance of new and used cascade impactors. J. Aerosol Med. 18(4):396-413 (2005).
17. A. Cripps, M. Riebe, M. Schulze, and R. Woodhouse. Pharmaceutical transition to non-CFC pressurized metered dose inhalers. Respir. Med. 94(SB):3-9 (2000).
18. S. J. Graham, R. C. Lawrence, E. D. Ormsby, and R. K. Pike. Particle size distribution of single and multiple sprays of salbutamol metered-dose inhalers (MDIs). Pharm. Res. 12(9):1380-1384 (1995).
19. A. Kamiya, M. Sakagami, M. Hindle, and P. Byron. Aerodynamic sizing of metered dose inhalers: An evaluation of the Andersen and Next Generation pharmaceutical impactors and their USP methods. J. Pharm. Sci. 93(7):1828-1837 (2004).
20. J. P. Mitchell. Practices of Coating Collection Surfaces of Cascade Impactors: A Survey of Members of the European Pharmaceutical Aerosol Group. Drug Delivery to the Lungs-14, The Aerosol Society, London, 2003, pp. 75-78.
21. US Federal Drug Administration (FDA). Draft guidance: Metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products chemistry, manufacturing and controls documentation. Docket 98D-0997 (1998).
22. Canadian Standards Association. Spacers and Holding Chambers for Use with Metered-Dose Inhalers, Canadian Standards Association, Mississauga, 2008CAN/CSA/Z264.1-02:2008.
23. M. B. Dolovich, and J. P. Mitchell. Canadian Standards Association (CSA) Standard Z264.1-02: A new voluntary standard for spacers and holding chambers used with pressurized metered-dose inhalers (pMDIs). Can. Respir. J. 11(7):489-495 (2004).
24. D. Christopher, W. Adams, A. Amann, C. Bertha, P. R. Byron, W. Doub, C. Dunbar, W. Hauck, S. Lyapustina, J. P. Mitchell, B. Morgan, S. Nichols, Z. Pan, G. J. P. Singh, T. Tougas, Y. Tsong, R. Wolff, and B. Wyka. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols: Part 3 - final report on a statistical procedure for determining equivalence. AAPS PharmSciTech. 8 (4):ARticle 90 (2007) doi: 10.1208/pt0804090 http://www.aapspharmscitech.org/. Accessed 5/10/2008.
25. J. P. Mitchell, P. A. Costa, and S. Waters. The calibration of Andersen Mark-II cascade impactors. AEE Winfrith (UK) Report AEEW-R 2162, December 1986.
26. J. P. Mitchell, P. A. Costa, and S. Waters. An assessment of an Andersen Mark-II cascade impactor. J. Aerosol Sci. 19(2):213-221 (1986).
27. N. P. Vaughan. The Andersen impactor: Calibration, wall losses and numerical simulation. J. Aerosol Sci. 20(1):67-90 (1989).
28. A. Kamiya, M. Sakagami, M. Hindle, and P. R. Byron. Particle sizing with the next generation impactor: A study of Vanceril™ metered dose inhaler. J. Aerosol Med. 16(2):216 (2003).
29. E. Berg, P. Lamb, A. Ali, J. Dennis, M. Tservistas, and J. Mitchell. Assessment of the need to coat particle collection cups of the NGI to mitigate droplet bounce when evaluating nebuliser-produced droplets. PharmEuropa Sci. Notes. 2008(1):21-26 (2008).
30. M. N. Nasr, D. L. Ross, and N. C. Miller. Effect of drug load and plate coating on the particle size distribution of a commercial albuterol metered dose inhaler (MDI) determined using the Andersen and Marple-Miller cascade impactors. Pharm. Res. 14(10):1437-1443 (1997).
31. T. L. Chan, and D. R. Lawson. Characteristics of cascade impactors in size determination of diesel particles. Atmos. Environ. 15(7):1273-1279 (1981).
32. S. W. Stein, and B. J. Gabrio. Understanding throat deposition during cascade impactor testing. In R. N. Dalby, P. R. Byron, S. J. Farr, and J. Peart (eds.), Respiratory Drug Delivery-VII, Serentec, Raleigh, 2000, pp. 573-576.